anmelden
Analysen von James Gordon
| 01.06.26 | AstraZeneca Overweight | Barclays Capital | |
| 28.05.26 | arGEN-X Overweight | Barclays Capital | |
| 26.05.26 | Roche Overweight | Barclays Capital | |
| 11.05.26 | arGEN-X Overweight | Barclays Capital | |
| 08.05.26 | arGEN-X Overweight | Barclays Capital | |
| 07.05.26 | arGEN-X Overweight | Barclays Capital | |
| 29.04.26 | AstraZeneca Overweight | Barclays Capital | |
| 28.04.26 | Roche Overweight | Barclays Capital | |
|
Werbung
|
|||
| 23.04.26 | Roche Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 30.03.26 | arGEN-X Overweight | Barclays Capital | |
| 27.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 12.03.26 | Roche Overweight | Barclays Capital | |
| 09.03.26 | Roche Overweight | Barclays Capital | |
| 27.02.26 | arGEN-X Overweight | Barclays Capital | |
| 26.02.26 | arGEN-X Overweight | Barclays Capital | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 20.01.26 | Bayer Overweight | Barclays Capital | |
| 15.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 15.01.26 | Roche Overweight | Barclays Capital | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.01.26 | Roche Overweight | Barclays Capital | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
